Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD
Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD have?
Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD has 18 citations in the OpenAlex counts ScholarIQ stores.
When was Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD published?
Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD has 2023 year in the ScholarIQ index.
What is the open-access status of Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD?
Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD has gold oa status in the ScholarIQ index.
What is the DOI of Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD?
The DOI for Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD is on the source record.
What is the PMID of Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD?
The PMID for Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD is on the source record.
What is the OpenAlex record for Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD?
The OpenAlex for Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD is on the source record.